 |
39 Diseases |  |
32 Trials |
|
32 Trials |  |
385 News |  |
| «123456 |
- | Cetrotide (cetrorelix) / EMD Serono
Trial initiation date: GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Jun 27, 2013
P3, N=100, Completed, Sponsor: Instituto Valenciano de Infertilidad, Spain
Initiation date: Dec 2010 --> Apr 2012
- | Cetrotide (cetrorelix) / EMD Serono
Enrollment change: GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Jun 27, 2013
P3, N=100, Completed, Sponsor: Instituto Valenciano de Infertilidad, Spain
Initiation date: Dec 2010 --> Apr 2012 N=62 --> 100
- | Cetrotide (cetrorelix) / EMD Serono
Trial completion: GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome (clinicaltrials.gov) - Jun 27, 2013
P3, N=100, Completed, Sponsor: Instituto Valenciano de Infertilidad, Spain
N=62 --> 100 Recruiting --> Completed
- | New P4 trial: Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist (clinicaltrials.gov) - Jun 26, 2013
P4, N=120, Completed, Sponsor: Universitair Ziekenhuis Brussel
- || Cetrotide (cetrorelix) / EMD Serono
New P2/3 trial: Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles (clinicaltrials.gov) - Feb 24, 2013
P2/3, N=150, Recruiting, Sponsor: National and Kapodistrian University of Athens
- Cetrotide (cetrorelix) / EMD Serono
Enrollment change: Use of Antagonist Versus Agonist GnRH in Oocyte Recipient Endometrium Preparation (clinicaltrials.gov) - Feb 13, 2013
P4, N=570, Completed, Sponsor: Instituto Valenciano de Infertilidad, Spain
Recruiting --> Completed N=400 --> 570
- | Cetrotide (cetrorelix) / EMD Serono
New P4 trial, Preclinical: Embryoscope: Assessment of Implantation Potential of Embryos by Time-lapse Technology (clinicaltrials.gov) - Jan 2, 2013
P4, N=200, Active, not recruiting, Sponsor: Bloom IVF and Fertility Centre
- Cetrotide (cetrorelix) / EMD Serono
Trial termination: Cetrotide Treatment Optimization (clinicaltrials.gov) - Dec 20, 2012
P4, N=617, Terminated, Sponsor: Bart CJM Fauser
N=400 --> 570 Recruiting --> Terminated; Due to limited rate of patient inclusion
- Cetrotide (cetrorelix) / EMD Serono
Enrollment change: Cetrotide Treatment Optimization (clinicaltrials.gov) - Dec 20, 2012
P4, N=617, Terminated, Sponsor: Bart CJM Fauser
Recruiting --> Terminated; Due to limited rate of patient inclusion N=2430 --> 617
- | Firmagon (degarelix) / Astellas, Ferring
Enrollment open: Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS) (clinicaltrials.gov) - Dec 19, 2012
P3, N=80, Recruiting, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
N=2430 --> 617 Not yet recruiting --> Recruiting
- || Firmagon (degarelix) / Astellas, Ferring
New P3 trial: Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS) (clinicaltrials.gov) - Oct 16, 2012
P3, N=80, Recruiting, Sponsor: Centre for Endocrinology and Reproductive Medicine, Italy
- leuprorelin depot / Generic mfg.
Clinical: Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation (clinicaltrials.gov) - Aug 19, 2012
P=N/A, N=40, Recruiting, Sponsor: Main Line Fertility Center
- Cetrotide (cetrorelix) / EMD Serono
Preclinical: Synchronization of Ovarian Stimulation for in Vitro Fertilization With Follicular Wave Emergence (clinicaltrials.gov) - Aug 15, 2012
P=N/A, N=30, Recruiting, Sponsor: University of Sao Paulo General Hospital
- Cetrotide (cetrorelix) / EMD Serono
Trial completion: Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days (clinicaltrials.gov) - Jul 11, 2012
P=N/A, N=96, Completed, Sponsor: Fertility - Assisted Fertilization Center
Not yet recruiting --> Recruiting Recruiting --> Completed
- || Suprefact (buserelin acetate) / Sanofi, Orgalutran (ganirelix acetate) / Organon, Cetrotide (cetrorelix) / EMD Serono
New P3 trial: The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol (clinicaltrials.gov) - Jul 8, 2012
P3, N=200, Not yet recruiting, Sponsor: European Hospital
- Cetrotide (cetrorelix) / EMD Serono
Enrollment open: Study on Influence of Leutinizing Hormone (LH) on Oocyte Maturity (clinicaltrials.gov) - May 23, 2012
P=N/A, N=300, Recruiting, Sponsor: Southern Cross Fertility Centre
Recruiting --> Completed Active, not recruiting --> Recruiting
- Cetrotide (cetrorelix) / EMD Serono
Trial completion: AGRA: Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis (clinicaltrials.gov) - May 2, 2012
P2, N=104, Completed, Sponsor: Betanien Hospital
Active, not recruiting --> Recruiting Active, not recruiting --> Completed
- leuprolide acetate for depot suspension / Generic mfg.
Trial withdrawal: Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy (clinicaltrials.gov) - Mar 19, 2012
P4, N=0, Withdrawn, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting --> Completed Completed --> Withdrawn
- leuprolide acetate for depot suspension / Generic mfg.
Enrollment change: Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy (clinicaltrials.gov) - Mar 19, 2012
P4, N=0, Withdrawn, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Completed --> Withdrawn N=108 --> 0
- Cetrotide (cetrorelix) / EMD Serono, Lutrelef (gonadorelin acetate) / Ferring
Enrollment closed: Reproductive Hormonal Alterations in Obesity (clinicaltrials.gov) - Mar 4, 2012
P=N/A, N=60, Active, not recruiting, Sponsor: University of Colorado, Denver
N=108 --> 0 Recruiting --> Active, not recruiting
- ||| Cetrotide (cetrorelix) / EMD Serono
Clinical: Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression (clinicaltrials.gov) - Feb 27, 2012
P=N/A, N=165, Not yet recruiting, Sponsor: University of Basel
- ||| Cetrotide (cetrorelix) / EMD Serono
Trial completion, Observational data: EMR200088-500: An Observational Study of Cetrotide® Gonadotropin-releasing Hormone Antagonist (GnRH Antagonist) With GONAL-f® in Assisted Reproductive Technologies (ART) (clinicaltrials.gov) - Jan 22, 2012
P=N/A, N=2175, Completed, Sponsor: Merck KGaA
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Cetrotide (cetrorelix) / EMD Serono
Trial completion: The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors (clinicaltrials.gov) - Oct 12, 2011
P=N/A, N=20, Completed, Sponsor: Virginia Center for Reproductive Medicine
Active, not recruiting --> Completed Enrolling by invitation --> Completed